BRIEF-Inotek Pharmaceuticals says evaluating strategic alternatives By: Reuters: Company News July 07, 2017 at 16:11 PM EDT * Inotek Pharmaceuticals announces top-line results of phase 2 fixed-dose combination trial of trabodenoson and provides corporate update Read More >>